检验医学与临床
檢驗醫學與臨床
검험의학여림상
JOURNAL OF LABORATORY MEDICINE AND CLINICAL SCIENCES
2014年
22期
3144-3146
,共3页
异丙托溴铵%特布他林%肺疾病%慢性阻塞性肺疾病
異丙託溴銨%特佈他林%肺疾病%慢性阻塞性肺疾病
이병탁추안%특포타림%폐질병%만성조새성폐질병
ipratropium bromide%terbutaILne%pulmonary disease%Chronic obstructive pulmonary disease
目的:探讨异丙托溴铵和特布他林联合应用对老年慢性阻塞性肺疾病患者的临床疗效、调节性T细胞、肺功能改善进行分析性比较研究。方法将2010~2013年该院收治的100例老年慢性阻塞性肺疾病患者随机分为两组,特布他林组50例,联合组50例。治疗前后监测临床疗效、肺功能和血气分析变化。并采用酶联免疫吸附试验检测各组受试者血清细胞因子肿瘤坏死因子‐α(TNF‐α)、白细胞介素‐8(IL‐8)变化。结果94例完成试验,两组有效率分别是87.67%、66.76%,联合组优于对照组(P<0.05)。治疗后,两组患者血氧分压,第1秒钟用力呼气容积、用力肺活量均较治疗前升高,二氧化碳分压较治疗前降低,组内比较差异均有统计学意义(P<0.05),且联合组优于特布他林组(P<0.05)。血清细胞因子TNF‐α、IL‐8水平与治疗前相比,水平明显下降,组内治疗前后比较,差异有统计学意义(P<0.05)。两组比较发现,联合组血清细胞因子TNF‐α、IL‐8水平明显下降,下降幅度大于特布他林组(P<0.05)。结论异丙托溴铵和特布他林可以提高临床疗效,增强肺功能,改善血清细胞因子指标,治疗效果更优。
目的:探討異丙託溴銨和特佈他林聯閤應用對老年慢性阻塞性肺疾病患者的臨床療效、調節性T細胞、肺功能改善進行分析性比較研究。方法將2010~2013年該院收治的100例老年慢性阻塞性肺疾病患者隨機分為兩組,特佈他林組50例,聯閤組50例。治療前後鑑測臨床療效、肺功能和血氣分析變化。併採用酶聯免疫吸附試驗檢測各組受試者血清細胞因子腫瘤壞死因子‐α(TNF‐α)、白細胞介素‐8(IL‐8)變化。結果94例完成試驗,兩組有效率分彆是87.67%、66.76%,聯閤組優于對照組(P<0.05)。治療後,兩組患者血氧分壓,第1秒鐘用力呼氣容積、用力肺活量均較治療前升高,二氧化碳分壓較治療前降低,組內比較差異均有統計學意義(P<0.05),且聯閤組優于特佈他林組(P<0.05)。血清細胞因子TNF‐α、IL‐8水平與治療前相比,水平明顯下降,組內治療前後比較,差異有統計學意義(P<0.05)。兩組比較髮現,聯閤組血清細胞因子TNF‐α、IL‐8水平明顯下降,下降幅度大于特佈他林組(P<0.05)。結論異丙託溴銨和特佈他林可以提高臨床療效,增彊肺功能,改善血清細胞因子指標,治療效果更優。
목적:탐토이병탁추안화특포타림연합응용대노년만성조새성폐질병환자적림상료효、조절성T세포、폐공능개선진행분석성비교연구。방법장2010~2013년해원수치적100례노년만성조새성폐질병환자수궤분위량조,특포타림조50례,연합조50례。치료전후감측림상료효、폐공능화혈기분석변화。병채용매련면역흡부시험검측각조수시자혈청세포인자종류배사인자‐α(TNF‐α)、백세포개소‐8(IL‐8)변화。결과94례완성시험,량조유효솔분별시87.67%、66.76%,연합조우우대조조(P<0.05)。치료후,량조환자혈양분압,제1초종용력호기용적、용력폐활량균교치료전승고,이양화탄분압교치료전강저,조내비교차이균유통계학의의(P<0.05),차연합조우우특포타림조(P<0.05)。혈청세포인자TNF‐α、IL‐8수평여치료전상비,수평명현하강,조내치료전후비교,차이유통계학의의(P<0.05)。량조비교발현,연합조혈청세포인자TNF‐α、IL‐8수평명현하강,하강폭도대우특포타림조(P<0.05)。결론이병탁추안화특포타림가이제고림상료효,증강폐공능,개선혈청세포인자지표,치료효과경우。
Objective To explore the effect of the combined therapy of Ipratropium bromide with terbutaILne on lung function and serum cytokines in elderly patients with chronic obstructive pulmonary disease .Methods A to‐tal of 100 elderly chronic obstructive pulmonary patients were randomly divided into terbutaILne group and combined group ,50 patients in each group .The cILnical efficacy after treatment ,changes in lung function and blood gas analysis were compared between the two groups .Serum cytokines TNF‐α,IL‐8 levels were tested by Enzyme‐ILnked immu‐nosorbent assays .Results A total of 94 patients completed the experiment .The efficiency of the two groups were 87 .67% and 66 .76% ,the combined group was significant higher than the control group (P< 0 .05) .After treat‐ment ,PaO2 ,FVC ,FEV1 of the two groups were all higher than those before treatment ,PaCO2 was lower than that before treatment ,differences were statistically significant (P<0 .05) ,and the combined group were better than the terbutaILne group (P<0 .05) .Serum cytokines TNF‐α,IL‐8 levels were significantly decreased after treatment(P<0 .05) .The serum cytokines TNF‐α,IL‐8 levels of the combined group decreased significantly larger than that of the terbutaILne group (P<0 .05) .Conclusion Ipratropium bromide and terbutaILne could improve cILnical outcomes , enhance lung function ,improve serum cytokines indicators ,and combined treatment is better .